Archive: 22/02/2017

Transplanting good bacteria to kill Staph

Healthy human skin is alive with bacteria. In fact, there are more microorganisms living in and on the human body than there are human cells. Most can live on the human skin without harming the host, but in some people bacteria ...

Feb 22, 2017

0

115

Accepting and adapting are keys to sustaining a career after acquired hearing loss

For adults who acquire severe hearing loss, accepting and adapting to the loss play key roles in sustaining a career and thriving in the workplace, new research from Oregon State University indicates.

Feb 22, 2017

Respiratory syncytial virus vaccine enters clinical testing

A Phase 1 clinical trial to test the safety and tolerability of an investigational vaccine against respiratory syncytial virus (RSV) has begun at the National Institutes of Health Clinical Center in Bethesda, Maryland. The ...

Feb 22, 2017

0

18

Health care's future: Turning patients into savers, shoppers

The U.S. government may soon lean on someone new to help lower health care costs: you.

Feb 22, 2017

0

0

Measuring patients' muscles to predict chemotherapy side effects

Chemotherapy has long been standard treatment for many cancers, but its clinical benefits can also come with well-documented side effects. Doctors say the challenge is knowing which patients will experience these side effects, ...

Feb 22, 2017

0

1

Autism risk linked to herpes infection during pregnancy

Women actively infected with genital herpes during early pregnancy had twice the odds of giving birth to a child later diagnosed with autism spectrum disorder (ASD), according to a study by scientists at the Center for Infection ...

Feb 22, 2017

0

169

CAR T cells more powerful when built with CRISPR, researchers find

Researchers from Memorial Sloan Kettering Cancer Center (MSK) have harnessed the power of CRISPR/Cas9 to create more-potent chimeric antigen receptor (CAR) T cells that enhance tumor rejection in mice. The unexpected findings, ...

Feb 22, 2017

Nature study suggests new therapy for Gaucher disease

Scientists propose in Nature blocking a molecule that drives inflammation and organ damage in Gaucher and maybe other lysosomal storage diseases as a possible treatment with fewer risks and lower costs than current therapies.

Feb 22, 2017